SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: atticus4paws who wrote (50711)1/31/2019 2:02:26 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 52153
 
Placebo group in VKTX/MDGL trials have higher relative and absolute liver fat reduction than placebo in BMY trial. Different and difficult population to treat????
Stile, diet, and life changes can also reduce liver fat content! Improvement in NASH. So, it is important to evaluate placebo response!